ATE382615T1 - Tocopherole, tocotrienole, andere chrome und seitenketten-derivate und ihre verwendung - Google Patents
Tocopherole, tocotrienole, andere chrome und seitenketten-derivate und ihre verwendungInfo
- Publication number
- ATE382615T1 ATE382615T1 AT01909008T AT01909008T ATE382615T1 AT E382615 T1 ATE382615 T1 AT E382615T1 AT 01909008 T AT01909008 T AT 01909008T AT 01909008 T AT01909008 T AT 01909008T AT E382615 T1 ATE382615 T1 AT E382615T1
- Authority
- AT
- Austria
- Prior art keywords
- chromes
- tocotrienols
- tocopherols
- side chain
- chain derivatives
- Prior art date
Links
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 title 1
- 229930003799 tocopherol Natural products 0.000 title 1
- 239000011732 tocopherol Substances 0.000 title 1
- 235000019149 tocopherols Nutrition 0.000 title 1
- 229930003802 tocotrienol Natural products 0.000 title 1
- 239000011731 tocotrienol Substances 0.000 title 1
- 235000019148 tocotrienols Nutrition 0.000 title 1
- 229940068778 tocotrienols Drugs 0.000 title 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 239000001301 oxygen Substances 0.000 abstract 3
- 239000011593 sulfur Chemical group 0.000 abstract 3
- 229910052717 sulfur Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/502,592 US6770672B1 (en) | 1998-09-23 | 2000-02-11 | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382615T1 true ATE382615T1 (de) | 2008-01-15 |
Family
ID=23998504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01909008T ATE382615T1 (de) | 2000-02-11 | 2001-02-09 | Tocopherole, tocotrienole, andere chrome und seitenketten-derivate und ihre verwendung |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7312232B2 (de) |
| EP (1) | EP1254130B1 (de) |
| JP (1) | JP2004504268A (de) |
| KR (1) | KR100847678B1 (de) |
| CN (1) | CN1243000C (de) |
| AT (1) | ATE382615T1 (de) |
| AU (2) | AU2001236805B2 (de) |
| CA (1) | CA2399802C (de) |
| DE (1) | DE60132171D1 (de) |
| IL (2) | IL151108A0 (de) |
| NZ (1) | NZ520798A (de) |
| RU (1) | RU2263672C2 (de) |
| WO (1) | WO2001058889A1 (de) |
| ZA (1) | ZA200206243B (de) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6703384B2 (en) | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| WO2001058889A1 (en) | 2000-02-11 | 2001-08-16 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| AUPR549901A0 (en) | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
| CN1262274C (zh) * | 2000-11-14 | 2006-07-05 | 生命健康科学有限公司 | 磷酸盐衍生物复合物 |
| CN1547475B (zh) * | 2001-07-27 | 2010-12-15 | 生命健康科学有限公司 | 含电子转移试剂的磷酸酯衍生物的皮肤制剂 |
| JP4624673B2 (ja) * | 2001-12-13 | 2011-02-02 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 化合物の経皮輸送 |
| US20030236301A1 (en) * | 2001-12-19 | 2003-12-25 | Bob Sanders | Liposomal delivery of vitamin E based compounds |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| JP4690305B2 (ja) * | 2003-01-17 | 2011-06-01 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 抗増殖性質を有する化合物 |
| AU2003901815A0 (en) * | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphate derivatives |
| GB0313612D0 (en) | 2003-06-12 | 2003-07-16 | Novartis Ag | Organic compounds |
| EP1664067A2 (de) * | 2003-09-15 | 2006-06-07 | DSM IP Assets B.V. | NEUE ROUTE ZU alpha-TOCOPHEROL, alpha-TOCOPHERYLALKANOATEN UND VORSTUFEN DAVON |
| DK1720551T3 (da) | 2004-03-03 | 2011-05-16 | Vital Health Sciences Pty Ltd | Alkaloidformuleringer |
| JP2008531602A (ja) * | 2005-03-03 | 2008-08-14 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 抗癌特性を有する化合物 |
| CA2611831C (en) | 2005-06-17 | 2014-09-16 | Vital Health Sciences Pty Ltd. | A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| RU2008123556A (ru) * | 2005-12-23 | 2010-01-27 | Вайтал Хэлф Сайнсис Пти Лтд (Au) | Составы, имеющие цитокин модулирующие свойства |
| AU2007217810B2 (en) * | 2006-02-21 | 2012-10-11 | The Ohio State University Research Foundation | Anticancer agents |
| EP2046315B1 (de) | 2006-06-02 | 2013-04-10 | The Ohio State University Research Foundation | Therapeutische mittel zur behandlung des mantelzell-lymphoms |
| US8288369B2 (en) * | 2006-06-27 | 2012-10-16 | University Of South Florida | Delta-tocotrienol treatment and prevention of pancreatic cancer |
| WO2009012096A2 (en) * | 2007-07-18 | 2009-01-22 | Research Development Foundation | Improved therapeutic methods and compositions comprising chroman ring compounds |
| RU2350620C1 (ru) * | 2007-07-23 | 2009-03-27 | Институт нефтехимии и катализа РАН | СПОСОБ ПОЛУЧЕНИЯ 6-O-[β-D-(2,3,4,6-ТЕТРА-O-АЦЕТИЛ)ГЛИКОПИРАНОЗИЛ]-d,l-α-ТОКОФЕРОЛОВ |
| USRE47300E1 (en) | 2008-03-14 | 2019-03-19 | Cancure Limited | Mitochondrially delivered anti-cancer compounds |
| CA2758823A1 (en) | 2009-04-13 | 2010-10-21 | The Ohio State University Research Foundation | Protein phosphatase 2a-activating agents |
| WO2010121111A1 (en) | 2009-04-17 | 2010-10-21 | The Ohio State University Research Foundation | Antiadhesion agents |
| AU2011213557B2 (en) | 2010-02-05 | 2015-05-07 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| RU2427323C1 (ru) * | 2010-02-25 | 2011-08-27 | Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" | Способ прогнозирования генерализации процесса при злокачественных опухолях костей |
| CA2794734C (en) | 2010-03-30 | 2017-12-12 | Phosphagenics Limited | Transdermal delivery patch |
| WO2012074960A2 (en) | 2010-11-29 | 2012-06-07 | The Ohio State University Research Foundation | Fty720-derived anticancer agents |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| KR20150030667A (ko) * | 2012-05-18 | 2015-03-20 | 더 오하이오 스테이트 유니버시티 | 간 기능을 개선시키는 방법 |
| WO2013184780A1 (en) * | 2012-06-06 | 2013-12-12 | Unither Virology, Llc | Novel iminosugars and their applications |
| NZ726849A (en) * | 2012-06-13 | 2018-06-29 | Cytec Tech Corp | Stabilizer compositions containing substituted chroman compounds and methods of use |
| AU2014318014C1 (en) * | 2013-09-06 | 2018-11-15 | Research Development Foundation | Alpha-tea salt forms: compositions and uses for treating disease |
| WO2015039029A1 (en) | 2013-09-13 | 2015-03-19 | The Board Of Trustees Of The University Of Arkansas | Preparation and use of a composition for prevention and mitigation of the effects of radiation |
| US20160324914A1 (en) | 2015-05-05 | 2016-11-10 | Tocol Pharmaceuticals, Llc | Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation |
| CN105078963B (zh) * | 2015-09-29 | 2018-06-22 | 中山大学 | α-生育酚在制备治疗血吸虫病药物中的应用 |
| CN108601732A (zh) | 2015-12-09 | 2018-09-28 | 磷肌酸有限公司 | 药物制剂 |
| MX392823B (es) | 2016-12-21 | 2025-03-24 | Avecho Biotechnology Ltd | Proceso de fosforilaciónde un alcohol complejo |
| KR20180002728U (ko) | 2017-03-10 | 2018-09-19 | 주식회사 두울온돌침대 | 전열 매트리스 |
| CA3135920A1 (en) * | 2020-10-28 | 2022-04-28 | Hermay Labs Corporation | SILENT LABLE AND COHERENT REDOX ANALOGS FOR VITAMIN E ENRICHMENT |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5118954B2 (de) * | 1972-02-04 | 1976-06-14 | ||
| CS172015B1 (de) | 1974-05-12 | 1976-12-29 | ||
| US4181725A (en) * | 1977-05-02 | 1980-01-01 | The Regents Of The University Of Michigan | Method for alleviating psoriasis |
| WO1979000401A1 (fr) * | 1977-12-16 | 1979-07-12 | Nisshin Flour Milling Co | Agent anti-tumeur |
| JPS6056155B2 (ja) | 1978-12-04 | 1985-12-09 | エーザイ株式会社 | クロマニルオキシ脂肪酸同族体 |
| US4457918A (en) * | 1982-05-12 | 1984-07-03 | The General Hospital Corporation | Glycosides of vitamins A, E and K |
| DE3309159A1 (de) * | 1983-03-15 | 1984-09-20 | Basf Ag, 6700 Ludwigshafen | Neue optisch aktive chromanderivate, verfahren zu deren herstellung sowie neue zwischenprodukte |
| US4873088A (en) * | 1983-09-06 | 1989-10-10 | Liposome Technology, Inc. | Liposome drug delivery method and composition |
| US4617317A (en) * | 1984-10-31 | 1986-10-14 | Bennet Justin D | Method of treating ulcerative colitis |
| EP0223831B1 (de) * | 1985-05-22 | 1992-07-15 | Liposome Technology, Inc. | Verfahren und system zum einatmen von liposomen |
| US4665204A (en) * | 1985-06-27 | 1987-05-12 | Henkel Corporation | Diester derivatives of tocopherol |
| JPS63203837A (ja) | 1987-02-17 | 1988-08-23 | 日清紡績株式会社 | 整経機における糸パツケ−ジ交換システム |
| JPS63303049A (ja) | 1987-06-04 | 1988-12-09 | Shinagawa Refract Co Ltd | 繊維強化ガラス質溶射材料 |
| JPS6441727A (en) | 1987-08-07 | 1989-02-14 | Toshiba Corp | Cooking unit |
| US5198432A (en) | 1988-01-29 | 1993-03-30 | Center For Innovative Technology | Method of preventing chlorohydrocarbon toxicity using sterol derivatives |
| US5610180A (en) * | 1988-01-29 | 1997-03-11 | Virginia Commonwealth University | Ionizable congeners of aromatic and aliphatic alcohols as anti-leukemia agents |
| US5260294A (en) * | 1988-08-09 | 1993-11-09 | Hoffman-La Roche Inc. | Chromanes and their pharmaceutical compositions and methods |
| JPH02215778A (ja) * | 1989-02-14 | 1990-08-28 | Kuraray Co Ltd | ３，４―ジヒドロ―２ｈ―ベンゾピラン誘導体及びその医薬用途 |
| JPH03206089A (ja) | 1990-01-05 | 1991-09-09 | Eisai Co Ltd | 新規ビタミンｅ誘導体及びその製造方法 |
| DE4014708C2 (de) | 1990-05-08 | 1994-03-10 | Heidelberger Druckmasch Ag | Verfahren zum Ermitteln von Registerfehlern |
| US5114957A (en) * | 1990-05-08 | 1992-05-19 | Biodor U.S. Holding | Tocopherol-based antiviral agents and method of using same |
| FR2672601B1 (fr) | 1991-02-08 | 1994-10-14 | Synthelabo | Derives de benzo-1,5-thiazepine, leur preparation et leur application en therapeutique. |
| JPH05213982A (ja) | 1991-03-26 | 1993-08-24 | Dainippon Ink & Chem Inc | オリゴ糖トコフェロール配糖体及び硫酸化オリゴ糖トコフェロール配糖体並びにこれを有効成分とする抗ウイルス剤 |
| FR2676056B1 (fr) * | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| EP0636618A1 (de) | 1991-06-04 | 1995-02-01 | Marigen S.A. | Spontan dispergierbare Konzentrate und Mikroemulsionen mit Vitamin-E-Verbindungen zur Herstellung von Arzneimitteln mit Antitumoraler Wirksamkeit |
| US5135945A (en) * | 1991-06-05 | 1992-08-04 | Merrell Dow Pharmaceuticals Inc. | Cholesterol-lowering tocopherol analogs |
| EP0543417A1 (de) * | 1991-11-22 | 1993-05-26 | Lipogenics, Incorporated | Tocotrienole und Focotrienol-ähnliche Verbindungen und Verfahren zu ihrer Verwendung |
| RU2098416C1 (ru) * | 1992-03-17 | 1997-12-10 | Басф Аг | Способ получения dl-альфа-токоферола или его ацетата |
| US5545660A (en) * | 1992-04-07 | 1996-08-13 | Merrell Pharmaceuticals Inc. | Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans |
| DE4215536A1 (de) * | 1992-05-12 | 1993-11-18 | Basf Ag | Cyan-Mischungen für den Farbstofftransfer |
| FR2695387B1 (fr) * | 1992-09-09 | 1994-10-21 | Adir | Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| US5403834A (en) * | 1992-12-07 | 1995-04-04 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| IT1256264B (it) * | 1992-12-31 | 1995-11-29 | Lifegroup Spa | N-acilderivati di idrossiammine dotati di attivita' scavenger ed utilizzabili nelle patologie acute e croniche correlate a fenomeni di perossidazione ed infiammazione |
| DE4304303C2 (de) | 1993-01-22 | 1997-01-30 | Pacific Corp | Vitamin-E-Derivate mit einem quartären Stickstoffatom, Verfahren zu deren Herstellung und kosmetische Mittel enthaltend dieselben |
| GB9301611D0 (en) * | 1993-08-04 | 1993-08-04 | Parisella Gerald | Dexterity game |
| CA2152693A1 (en) * | 1994-08-05 | 1996-02-06 | Kazumi Ogata | Therapeutic composition for pancreatitis |
| US5670255A (en) * | 1995-01-23 | 1997-09-23 | Ppg Industries, Inc. | Antioxidant compositions for coating substrates, substrates coated with the same and methods for inhibiting the oxidation of such compositions applied to a substrate |
| DE19504398A1 (de) * | 1995-02-10 | 1996-08-14 | Beiersdorf Ag | Tocopherylglycoside, ihre Herstellung sowie ihre Verwendung als Tenside, als Antioxidantien sowie als der Zellalterung vorbeugender Wirkstoff in kosmetischen oder pharmazeutischen Zubereitungen |
| DE19523079A1 (de) | 1995-06-26 | 1997-01-02 | Basf Ag | Ester und Amide der 9(Z)-Retinsäure |
| CA2179940A1 (en) | 1995-07-18 | 1997-01-19 | Kazumi Ogata | Antiallergic composition comprising a phosphoric diester compound |
| US5798356A (en) | 1995-08-07 | 1998-08-25 | Alcon Laboratories, Inc. | Angiostatic compounds |
| CA2186654A1 (en) | 1995-10-13 | 1997-04-14 | Masayuki Nakamura | Phosphoric diester |
| JPH09301953A (ja) * | 1996-03-12 | 1997-11-25 | Sanwa Kagaku Kenkyusho Co Ltd | マロン酸ジアミド誘導体及びその用途 |
| JPH104489A (ja) * | 1996-04-19 | 1998-01-06 | Nikon Corp | 画像入力装置 |
| JPH09301969A (ja) * | 1996-05-15 | 1997-11-25 | Fuji Photo Film Co Ltd | クロマン系化合物及びそれを使用する感熱記録材料 |
| US5827878A (en) * | 1996-07-01 | 1998-10-27 | Nisshin Flour Milling Co., Ltd. | Pharmaceutical composition for the treatment of leukemia containing 9-cis-retinoic acid-α-tocopherol ester |
| US6022560A (en) * | 1996-08-27 | 2000-02-08 | Clarion Pharmaceuticals Inc. | Pharmaceutical compositions, novel uses, and novel form of α-tocopherylphosphocholine |
| FR2754713B1 (fr) | 1996-10-22 | 1999-01-08 | Roc Sa | Utilisation de complexes pour la preparation de compositions pour le traitement des peaux sensibles, procede de preparation et compositions hypoallergeniques |
| AU729355B2 (en) * | 1997-03-04 | 2001-02-01 | Wisconsin Alumni Research Foundation | Method of suppressing tumor growth with combinations of isoprenoids and statins |
| CA2220541A1 (en) | 1997-11-07 | 1999-05-07 | Mcgill University | Analogs of vitamin e |
| US5917060A (en) * | 1997-12-17 | 1999-06-29 | Basf Aktiengesellschaft | Preparation of chromanyl derivatives |
| CN1318413C (zh) * | 1998-09-23 | 2007-05-30 | 研究发展基金会 | 生育酚、生育三烯酚、其它苯并二氢吡喃和侧链衍生物,及其用途 |
| US6703384B2 (en) | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| US6770672B1 (en) * | 1998-09-23 | 2004-08-03 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| FR2784988B1 (fr) * | 1998-10-23 | 2002-09-20 | Adir | Nouveaux composes dihydro et tetrahydroquinoleiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US5990322A (en) * | 1999-03-09 | 1999-11-23 | Sk Corporation | Alpha-tocopherol cyclopropylates, the new vitamin E derivatives and method for producing the same |
| US6127382A (en) * | 1999-08-16 | 2000-10-03 | Allergan Sales, Inc. | Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| WO2001058889A1 (en) * | 2000-02-11 | 2001-08-16 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| US20030236301A1 (en) * | 2001-12-19 | 2003-12-25 | Bob Sanders | Liposomal delivery of vitamin E based compounds |
| AU2003231010A1 (en) * | 2002-04-19 | 2003-11-03 | Research Development Foundation | Tocopherol associated protein and uses thereof |
-
2001
- 2001-02-09 WO PCT/US2001/004168 patent/WO2001058889A1/en not_active Ceased
- 2001-02-09 RU RU2002124135/04A patent/RU2263672C2/ru not_active IP Right Cessation
- 2001-02-09 AU AU2001236805A patent/AU2001236805B2/en not_active Ceased
- 2001-02-09 CA CA002399802A patent/CA2399802C/en not_active Expired - Fee Related
- 2001-02-09 NZ NZ520798A patent/NZ520798A/en not_active IP Right Cessation
- 2001-02-09 DE DE60132171T patent/DE60132171D1/de not_active Expired - Lifetime
- 2001-02-09 JP JP2001558439A patent/JP2004504268A/ja not_active Ceased
- 2001-02-09 AU AU3680501A patent/AU3680501A/xx active Pending
- 2001-02-09 EP EP01909008A patent/EP1254130B1/de not_active Expired - Lifetime
- 2001-02-09 AT AT01909008T patent/ATE382615T1/de not_active IP Right Cessation
- 2001-02-09 CN CNB018075363A patent/CN1243000C/zh not_active Expired - Fee Related
- 2001-02-09 KR KR1020027010387A patent/KR100847678B1/ko not_active Expired - Fee Related
- 2001-02-09 IL IL15110801A patent/IL151108A0/xx active IP Right Grant
-
2002
- 2002-08-06 IL IL151108A patent/IL151108A/en not_active IP Right Cessation
- 2002-08-06 ZA ZA200206243A patent/ZA200206243B/xx unknown
-
2003
- 2003-08-20 US US10/644,418 patent/US7312232B2/en not_active Expired - Fee Related
-
2007
- 2007-10-22 US US11/876,612 patent/US7608638B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7312232B2 (en) | 2007-12-25 |
| IL151108A (en) | 2006-08-01 |
| AU3680501A (en) | 2001-08-20 |
| AU2001236805B2 (en) | 2005-07-14 |
| NZ520798A (en) | 2004-05-28 |
| WO2001058889A1 (en) | 2001-08-16 |
| IL151108A0 (en) | 2003-04-10 |
| EP1254130B1 (de) | 2008-01-02 |
| CA2399802A1 (en) | 2001-08-16 |
| US20040235938A1 (en) | 2004-11-25 |
| CN1243000C (zh) | 2006-02-22 |
| EP1254130A4 (de) | 2003-04-23 |
| US7608638B2 (en) | 2009-10-27 |
| ZA200206243B (en) | 2009-10-28 |
| EP1254130A1 (de) | 2002-11-06 |
| DE60132171D1 (de) | 2008-02-14 |
| US20080119514A1 (en) | 2008-05-22 |
| KR20030005186A (ko) | 2003-01-17 |
| RU2263672C2 (ru) | 2005-11-10 |
| JP2004504268A (ja) | 2004-02-12 |
| CN1529701A (zh) | 2004-09-15 |
| KR100847678B1 (ko) | 2008-07-23 |
| CA2399802C (en) | 2009-12-08 |
| RU2002124135A (ru) | 2004-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE382615T1 (de) | Tocopherole, tocotrienole, andere chrome und seitenketten-derivate und ihre verwendung | |
| DE69910831D1 (de) | Epothilonderivate und ihre verwendung als antitumormittel | |
| BG106390A (en) | Novel spiro compounds | |
| PT778277E (pt) | Derivados heterociclicos substituidos como antagonistas do crf | |
| DK1392666T3 (da) | Biologisk aktive methylenblåt-derivater | |
| ES2053609T3 (es) | Derivados de urea inhibidores de lipoxigenasa. | |
| NZ505968A (en) | Sulfonylamino derivatives which inhibit matrix- degrading metallproteinases | |
| PT1453512E (pt) | Derivados de acetileno tendo actividade antagonistica do mglur 5 | |
| ATE248824T1 (de) | Substituierte phenylderivate, ihre herstellung und verwendung | |
| ATE222894T1 (de) | Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien | |
| ATE227277T1 (de) | Isoxazoline derivate und ihre verwendung als antimikroben | |
| DK1042319T3 (da) | Dihydrobenzofuraner | |
| TR200000907T2 (tr) | Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri. | |
| ATE327979T1 (de) | Pyrazolinon-derivate | |
| ATE278697T1 (de) | Katalysatoren | |
| BG101221A (bg) | N-заместени азабициклохептанови производни, приложими като невролептици | |
| DE69529680D1 (de) | 2',5'-phosphorthioat/phosphodiester-oligoadenylate und ihre antiviralen verwendungen | |
| TR199801902A2 (xx) | S�lfonamid ile s�bstit�e edilmi� kromanlar, bunlar� i�eren farmakolojik bile�imler. | |
| EP0641768A4 (de) | Nitroxyalkylamid-derivate. | |
| DE59200787D1 (de) | 6-Thiono-5,6-dihydro-dibenz[b,e]azepin-11-on-11-oxime und ihre Verwendung als retrovirale Mittel. | |
| ATE305298T1 (de) | 4,5-dihydro-2-thiazolylaminderivate und ihre verwendung als no-synthase inhibitoren | |
| ATE252530T1 (de) | 1,4-diaryl-2-fluor-1-buten-3-ol-verbindungen und ihre verwendung in der herstellung von 1,4-diaryl-2-fluor-1,3-butadien- und 1,4-diaryl-2-fluor-2- buten-verbindungen | |
| DE59905342D1 (de) | N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung | |
| PL373989A1 (en) | Novel benzonaphthyridines | |
| DE60021914D1 (de) | Triazatrinaphthyrinen und ihre verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |